8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001564590-15-005015
Material agreement · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading abio-8k_20150610.htm…